Comer Amber R, Fettig Lyle, Bartlett Stephanie, Sinha Shilpee, D'Cruz Lynn, Odgers Aubrey, Waite Carly, Slaven James E, White Ryan, Schmidt Amanda, Petras Laura, Torke Alexia M
Indiana University School of Health and Human Science, United States.
Indiana University School of Medicine, United States.
Resusc Plus. 2023 Aug 23;15:100452. doi: 10.1016/j.resplu.2023.100452. eCollection 2023 Sep.
The COVID-19 pandemic created complex challenges regarding the timing and appropriateness of do-not-attempt cardiopulmonary resuscitation (DNACPR) and/or Do Not Intubate (DNI) code status orders. This paper sought to determine differences in utilization of DNACPR and/or DNI orders during different time periods of the COVID-19 pandemic, including prevalence, predictors, timing, and outcomes associated with having a documented DNACPR and/or DNI order in hospitalized patients with COVID-19.
A cohort study of hospitalized patients with COVID-19 at two hospitals located in the Midwest. DNACPR code status orders including, DNI orders, demographics, labs, COVID-19 treatments, clinical interventions during hospitalization, and outcome measures including mortality, discharge disposition, and hospice utilization were collected. Patients were divided into two time periods (early and late) by timing of hospitalization during the first wave of the pandemic (March-October 2020).
Among 1375 hospitalized patients with COVID-19, 19% ( = 258) of all patients had a documented DNACPR and/or DNI order. In multivariable analysis, age (older) =< 0.01, OR 1.12 and hospitalization early in the pandemic = 0.01, OR 2.08, were associated with having a DNACPR order. Median day from DNACPR order to death varied between cohorts => 0.01 (early cohort 5 days versus late cohort 2 days). In-hospital mortality did not differ between cohorts among patients with DNACPR orders, = 0.80.
There was a higher prevalence of DNACPR and/or DNI orders and these orders were written earlier in the hospital course for patients hospitalized early in the pandemic versus later despite similarities in clinical characteristics and medical interventions. Changes in clinical care between cohorts may be due to fear of resource shortages and changes in knowledge about COVID-19.
新冠疫情给不进行心肺复苏(DNACPR)和/或不插管(DNI)医嘱的时机及合理性带来了复杂挑战。本文旨在确定新冠疫情不同时期DNACPR和/或DNI医嘱的使用差异,包括新冠住院患者中记录有DNACPR和/或DNI医嘱的患病率、预测因素、时机及结局。
对位于美国中西部的两家医院的新冠住院患者进行队列研究。收集DNACPR医嘱(包括DNI医嘱)、人口统计学信息、实验室检查结果、新冠治疗情况、住院期间的临床干预措施以及结局指标,包括死亡率、出院处置方式和临终关怀使用情况。根据疫情第一波期间(2020年3月至10月)的住院时间将患者分为两个时期(早期和晚期)。
在1375例新冠住院患者中,19%(n = 258)的患者有记录的DNACPR和/或DNI医嘱。多变量分析显示,年龄较大(<0.01,OR 1.12)以及疫情早期住院(= 0.01,OR 2.08)与有DNACPR医嘱相关。从DNACPR医嘱到死亡的中位天数在不同队列间有所不同(>0.01,早期队列5天,晚期队列2天)。有DNACPR医嘱的患者中,不同队列的院内死亡率无差异(= 0.80)。
DNACPR和/或DNI医嘱的患病率较高,尽管临床特征和医疗干预措施相似,但疫情早期住院的患者与晚期住院的患者相比,这些医嘱在住院过程中开具得更早。不同队列间临床护理的变化可能是由于对资源短缺的担忧以及对新冠认识的改变。